Literature DB >> 3259091

Pharmacokinetics of propofol administered by continuous infusion in patients with cirrhosis. Preliminary results.

F Servin1, J M Desmonts, R Farinotti, J P Haberer, C Winckler.   

Abstract

Anaesthesia was provided by an infusion of propofol in six healthy patients and six patients with hepatic cirrhosis. There were no significant differences between the groups with regard to the central compartment volume, distribution volume at steady state, total apparent distribution volume, total body clearance or elimination half-life, although the values were always greater in the cirrhotic patients. Recovery times were significantly longer in the patients with cirrhosis.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3259091     DOI: 10.1111/j.1365-2044.1988.tb09063.x

Source DB:  PubMed          Journal:  Anaesthesia        ISSN: 0003-2409            Impact factor:   6.955


  6 in total

1.  Kidneys contribute to the extrahepatic clearance of propofol in humans, but not lungs and brain.

Authors:  Haruhiko Hiraoka; Koujirou Yamamoto; Soutarou Miyoshi; Toshihiro Morita; Katsunori Nakamura; Yuuji Kadoi; Fumio Kunimoto; Ryuya Horiuchi
Journal:  Br J Clin Pharmacol       Date:  2005-08       Impact factor: 4.335

2.  Application of a physiologically based pharmacokinetic model to assess propofol hepatic and renal glucuronidation in isolation: utility of in vitro and in vivo data.

Authors:  Katherine L Gill; Michael Gertz; J Brian Houston; Aleksandra Galetin
Journal:  Drug Metab Dispos       Date:  2013-01-09       Impact factor: 3.922

3.  Propofol versus midazolam for upper gastrointestinal endoscopy in cirrhotic patients: a meta-analysis of randomized controlled trials.

Authors:  Hsiao-Chien Tsai; Yu-Cih Lin; Ching-Lung Ko; Horng-Yuan Lou; Ta-Liang Chen; Ka-Wai Tam; Chien-Yu Chen
Journal:  PLoS One       Date:  2015-02-03       Impact factor: 3.240

4.  Safety, pharmacokinetics and pharmacodynamics of a novel γ-aminobutyric acid (GABA) receptor potentiator, HSK3486, in Chinese patients with hepatic impairment.

Authors:  Yue Hu; Xiaojiao Li; Jingrui Liu; Hong Chen; Wenbo Zheng; Hong Zhang; Min Wu; Cuiyun Li; Xiaoxue Zhu; Jinfeng Lou; Pangke Yan; Nan Wu; Xiao Liu; Shiping Ma; Xu Wang; Yanhua Ding; Chengluan Xuan
Journal:  Ann Med       Date:  2022-12       Impact factor: 5.348

Review 5.  Pre-procedural Preparation and Sedation for Gastrointestinal Endoscopy in Patients with Advanced Liver Disease.

Authors:  Brian M Fung; Deanna J Leon; Lauren N Beck; James H Tabibian
Journal:  Dig Dis Sci       Date:  2021-06-24       Impact factor: 3.487

Review 6.  Optimizing sedation in patients with acute brain injury.

Authors:  Mauro Oddo; Ilaria Alice Crippa; Sangeeta Mehta; David Menon; Jean-Francois Payen; Fabio Silvio Taccone; Giuseppe Citerio
Journal:  Crit Care       Date:  2016-05-05       Impact factor: 9.097

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.